Lv41
580 积分 2023-05-15 加入
Izalontamab brengitecan, an EGFR and HER3 bispecific antibody–drug conjugate, versus chemotherapy in heavily pretreated recurrent or metastatic nasopharyngeal carcinoma: a multicentre, randomised, open-label, phase 3 study in China
3天前
已完结
Interactions of Antibody Drug Conjugate Anti‐Tubulin and Topoisomerase I Inhibitor Payloads with Radiotherapy to Potentiate Immunotherapy
10天前
已完结
Stoichiometric Antibody–Polymer–Drug Conjugate for Effective Low-Dose Treatment of Breast Cancer
17天前
已完结
Analytical tools for antibody–drug conjugates: From in vitro to in vivo
1个月前
已完结
Antibody-drug conjugates: Principles and opportunities
2个月前
已完结
Exploring the next generation of antibody–drug conjugates
2个月前
已完结
Antibody-Drug Conjugate-Based Therapeutics: State of the Science
2个月前
已完结
Engineering functional electroconductive hydrogels for targeted therapy in myocardial infarction repair
5个月前
已完结
Hydrogels loaded with MSC‐derived small extracellular vesicles: A novel cell‐free tissue engineering system for diabetic wound management
1年前
已完结
A Multifunctional Anisotropic Patch Manufactured by Microfluidic Manipulation for the Repair of Infarcted Myocardium
1年前
已完结
皖公网安备34019202002308
